Engineering Targeting Materials for Therapeutic Cancer Vaccines
Therapeutic cancer vaccines constitute a valuable tool to educate the immune system to fight tumors and prevent cancer relapse. Nevertheless, the number of cancer vaccines in the clinic remains very limited to date, highlighting the need for further technology development. Recently, cancer vaccines...
Main Authors: | Priscilla S. Briquez, Sylvie Hauert, Alexandre de Titta, Laura T. Gray, Aaron T. Alpar, Melody A. Swartz, Jeffrey A. Hubbell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2020.00019/full |
Similar Items
-
Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis
by: Lucas S. Shores, et al.
Published: (2020-08-01) -
Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control
by: Natalia K. Botelho, et al.
Published: (2019-02-01) -
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance
by: Chitavi D. Maulloo, et al.
Published: (2021-09-01) -
Editorial: ImmunoPhysics and ImmunoEngineering
by: Jorge Bernardino de la Serna, et al.
Published: (2020-02-01) -
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice.
by: Iraklis C Kourtis, et al.
Published: (2013-01-01)